Victor William Nitti

Title(s)Professor, Urology
SchoolMedicine
Address
vCardDownload vCard
    Other Positions
    Title(s)Professor, Obstetrics and Gynecology


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Impact of Fellowship-Trained Andrology and Sexual Medicine Specialists on Performance on the Annual American Urological Association In-Service Examination. Urology. 2021 Jun 26. El-Arabi AM, Alam SM, Dai J, Thompson J, Baden M, Siculietano J, Kerley P, Englert S, Nitti VW, Hussman DA, Thrasher JB, Brannigan RE, Sandlow JI, Nangia PAK. PMID: 34186132.
      View in: PubMed   Mentions:    Fields:    
    2. Estimation of Urinary Frequency: Does Question Phrasing Matter? Urology. 2021 Apr 24. Sussman RD, Escobar C, Jericevic D, Oh C, Arslan A, Palmerola R, Pape DM, Smilen SW, Nitti VW, Rosenblum N, Brucker BM. PMID: 33901531.
      View in: PubMed   Mentions:    Fields:    
    3. The Effect of Symptomatic Stress Urinary Incontinence on Catheterization Rates After Intradetrusor OnabotulinumtoxinA Injections. Female Pelvic Med Reconstr Surg. 2021 Mar 24. Brandon C, Pape DM, Oh C, Kreines FM, Thakker SS, Rosenblum N, Nitti VW, Brucker BM, Glass D. PMID: 34009831.
      View in: PubMed   Mentions:    Fields:    
    4. Diagnosis and management of overactive bladder: A review. J Obstet Gynaecol Res. 2021 May; 47(5):1654-1665. Nitti VW, Patel A, Karram M. PMID: 33592680.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Persistence in Percutaneous Tibial Nerve Stimulation Treatment for Overactive Bladder Syndrome is Best Predicted by Patient Global Impression of Improvement Rather Than Symptom-Specific Improvement. Urology. 2021 Feb; 148:93-99. Brandon C, Oh C, Brucker BM, Rosenblum N, Ferrante KL, Smilen SW, Nitti VW, Pape DM. PMID: 33358753.
      View in: PubMed   Mentions:    Fields:    
    6. Gel-Infused Translabial Ultrasound in the Evaluation of Female Urethral Stricture. Female Pelvic Med Reconstr Surg. 2020 12 01; 26(12):737-741. Sussman RD, Kozirovsky M, Telegrafi S, Peyronnet B, Palmerola R, Smilen S, Pape DM, Rosenblum N, Nitti VW, Brucker BM. PMID: 30664026.
      View in: PubMed   Mentions:    Fields:    
    7. Rectus Fascia Versus Fascia Lata for Autologous Fascial Pubovaginal Sling: A Single-Center Comparison of Perioperative and Functional Outcomes. Female Pelvic Med Reconstr Surg. 2020 08; 26(8):493-497. Peng M, Sussman RD, Escobar C, Palmerola R, Pape DM, Smilen SS, Rosenblum N, Brucker BM, Peyronnet B, Nitti VW. PMID: 31343622.
      View in: PubMed   Mentions:    Fields:    
    8. Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials. Neurourol Urodyn. 2020 02; 39(2):744-753. Rovner E, Chai TC, Jacobs S, Christ G, Andersson KE, Efros M, Nitti V, Davies K, McCullough AR, Melman A. PMID: 31945197.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    9. Radiation exposure during videourodynamic testing: Is dose reduction possible using a standardized protocol? Neurourol Urodyn. 2020 02; 39(2):715-720. Hoffman D, Sussman RD, Pape DM, Smilen SW, Rosenblum N, Nitti VW, Brucker BM. PMID: 31846117.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    10. Current Role of Urethrolysis and Partial Excision in Patients Seeking Revision of Anti-Incontinence Sling. Female Pelvic Med Reconstr Surg. 2019 Nov/Dec; 25(6):409-414. Drain A, Enemchukwu E, Shah N, Syan R, Rosenblum N, Nitti VW, Brucker BM. PMID: 29787462.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease. Int Neurourol J. 2019 Sep; 23(3):211-218. Vurture G, Peyronnet B, Palma JA, Sussman RD, Malacarne DR, Feigin A, Palmerola R, Rosenblum N, Frucht S, Kaufmann H, Nitti VW, Brucker BM. PMID: 31607100.
      View in: PubMed   Mentions:
    12. Impact of preoperative urodynamics on women undergoing pelvic organ prolapse surgery. Int Urogynecol J. 2020 08; 31(8):1663-1668. Glass D, Lin FC, Khan AA, Van Kuiken M, Drain A, Siev M, Peyronett B, Rosenblum N, Brucker BM, Nitti VW. PMID: 31456030.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Incontinence after Prostate Treatment: AUA/SUFU Guideline. J Urol. 2019 08; 202(2):369-378. Sandhu JS, Breyer B, Comiter C, Eastham JA, Gomez C, Kirages DJ, Kittle C, Lucioni A, Nitti VW, Stoffel JT, Westney OL, Murad MH, McCammon K. PMID: 31059663.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    14. Trends in Stress Urinary Incontinence Surgery at a Tertiary Center: Midurethral Sling Use Following the AUGS/SUFU Position Statement. Urology. 2019 09; 131:71-76. Palmerola R, Peyronnet B, Rebolos M, Khan A, Sussman RD, Escobar C, Smith S, Rosenblum N, Nitti VW. PMID: 31229514.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome. Urology. 2019 Sep; 131:77-82. Kobashi K, Nitti V, Margolis E, Sand P, Siegel S, Khandwala S, Newman D, MacDiarmid SA, Kan F, Michaud E. PMID: 31199966.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre. Arab J Urol. 2019 Mar; 17(1):82-86. Drangsholt S, Peyronnet B, Arcila-Ruiz M, Sussman RD, Palmerola R, Pape DR, Rosenblum N, Nitti VW, Brucker BM. PMID: 31258948.
      View in: PubMed   Mentions:
    17. Exploring stress urinary incontinence outcomes after sling excision for perforation or exposure. Low Urin Tract Symptoms. 2019 Sep; 11(4):206-210. Syan R, Peyronnet B, Drain A, Enemchukwu E, Malacarne DR, Rosenblum N, Nitti VW, Brucker BM. PMID: 30900401.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladder. Neurourol Urodyn. 2019 03; 38(3):996-1004. Uren AD, Cotterill N, Harding C, Hillary C, Chapple C, Lasch K, Stroupe A, Deshpande C, Delbecque L, Van Koeveringe G, Oelke M, Belal M, Bosch R, Blok B, Nitti V, Gotoh M, Takei M, Crawford B, Klaver M, Bongaerts D, Hakimi Z, Kos T, Abrams P. PMID: 30801826.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Effect of Radiation on Male Stress Urinary Incontinence and the Role of Urodynamic Assessment. Urology. 2019 Mar; 125:58-63. Hoffman D, Vijay V, Peng M, Sussman RD, Rosenblum N, Brucker BM, Peyronnet B, Nitti VW. PMID: 30508511.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. AMS-800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic review. Neurourol Urodyn. 2019 08; 38 Suppl 4:S28-S41. Peyronnet B, O'Connor E, Khavari R, Capon G, Manunta A, Allue M, Hascoet J, Nitti VW, Gamé X, Gilleran J, Castro-Sader L, Cornu JN, Waltregny D, Ahyai S, Chung E, Elliott DS, Fournier G, Brucker BM. PMID: 30298943.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    21. Diagnosis and management of nocturia in current clinical practice: who are nocturia patients, and how do we treat them? World J Urol. 2019 Jul; 37(7):1389-1394. Drangsholt S, Ruiz MJA, Peyronnet B, Rosenblum N, Nitti V, Brucker B. PMID: 30288596.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. Terminology report from the International Continence Society (ICS) Working Group on Underactive Bladder (UAB). Neurourol Urodyn. 2018 11; 37(8):2928-2931. Chapple CR, Osman NI, Birder L, Dmochowski R, Drake MJ, van Koeveringe G, Nitti VW, Oelke M, Smith PP, Yamaguchi O, Wein A, Abrams P. PMID: 30203560.
      View in: PubMed   Mentions: 5     Fields:    
    23. Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort. Parkinsonism Relat Disord. 2018 12; 57:22-26. Peyronnet B, Vurture G, Palma JA, Malacarne DR, Feigin A, Sussman RD, Biagioni MC, Palmerola R, Gilbert R, Rosenblum N, Frucht S, Kaufmann H, Nitti VW, Brucker BM. PMID: 30037689.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's disease. Neurourol Urodyn. 2018 11; 37(8):2669-2677. Vurture G, Peyronnet B, Feigin A, Biagioni MC, Gilbert R, Rosenblum N, Frucht S, Di Rocco A, Nitti VW, Brucker BM. PMID: 29767449.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. The history of the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction. Neurourol Urodyn. 2018 08; 37(6):2015-2025. Weissbart SJ, Zimmern PE, Nitti VW, Lemack GE, Kobashi KC, Vasavada SP, Wein AJ. PMID: 29575219.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Botulinum Toxin Use in Neurourology. Rev Urol. 2018; 20(2):84-93. Peyronnet B, Gamé X, Vurture G, Nitti VW, Brucker BM. PMID: 30288145.
      View in: PubMed   Mentions:
    27. Surgical Treatment of Male Postprostatectomy Incontinence: Current Concepts. Eur Urol Focus. 2017 10; 3(4-5):364-376. Kretschmer A, Nitti V. PMID: 29174616.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis. BJU Int. 2017 11; 120(5):611-622. Drake MJ, Nitti VW, Ginsberg DA, Brucker BM, Hepp Z, McCool R, Glanville JM, Fleetwood K, James D, Chapple CR. PMID: 28670786.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    29. Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder. J Urol. 2017 10; 198(4):897-904. Ginsberg DA, Drake MJ, Kaufmann A, Radomski S, Gousse AE, Chermansky CJ, Magyar A, Nicandro JP, Nitti VW, 191622-096 Investigators . PMID: 28536084.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    30. Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies. Ther Adv Urol. 2017 Dec; 9(6):137-154. Tubaro A, Batista JE, Nitti VW, Herschorn S, Chapple CR, Blauwet MB, Siddiqui E, Huang M, Oelke M. PMID: 28588652.
      View in: PubMed   Mentions:
    31. Midurethral sling erosion: NYU Case of the Month, August 2017. Rev Urol. 2017; 19(3):185-186. Nitti VW. PMID: 29302242.
      View in: PubMed   Mentions:
    32. Risk Factors for Urinary Tract Infection following Mid Urethral Sling Surgery. J Urol. 2017 05; 197(5):1268-1273. Vigil HR, Mallick R, Nitti VW, Lavallée LT, Breau RH, Hickling DR. PMID: 28034608.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    33. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial. J Urol. 2017 02; 197(2S):S216-S223. Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C, EMBARK Study Group . PMID: 28012773.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    34. Radiation Exposure During Videourodynamics: Establishing Risk Factors. Low Urin Tract Symptoms. 2018 May; 10(2):181-185. Brucker BM, Campeau L, Fong E, Kalra S, Rosenblum N, Nitti VW. PMID: 27990783.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    35. Use of Concomitant Stress Incontinence Surgery at Time of Pelvic Organ Prolapse Surgery Since Release of the 2011 Notification on Serious Complications Associated with Transvaginal Mesh. J Urol. 2017 04; 197(4):1092-1098. Drain A, Khan A, Ohmann EL, Brucker BM, Smilen S, Rosenblum N, Nitti VW. PMID: 27866958.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. Post-Sling Urinary Retention in Women. Curr Urol Rep. 2016 Nov; 17(11):83. Malacarne DR, Nitti VW. PMID: 27678391.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms. Neurourol Urodyn. 2017 Apr; 36(4):1208-1213. Brucker BM, Nitti VW, Kalra S, Herbert J, Sadiq A, Utomo P, Aponte MM. PMID: 27548624.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    38. Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications. Neurourol Urodyn. 2017 04; 36(4):1155-1160. Rac G, Younger A, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, MacLachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner ES. PMID: 27460448.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    39. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol. 2016 Sep; 196(3):801-8. Rovner E, Kohan A, Chartier-Kastler E, Jünemann KP, Del Popolo G, Herschorn S, Joshi M, Magyar A, Nitti V. PMID: 27091236.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    40. Clinical Case Discussion: Failure of a Midurethral Sling Procedure for Stress Urinary Incontinence in a Female Patient. Eur Urol Focus. 2016 Aug; 2(3):335-336. Drain A, Nitti VW. PMID: 28723384.
      View in: PubMed   Mentions:    Fields:    
    41. Female Bladder Outlet Obstruction. Curr Urol Rep. 2016 Apr; 17(4):31. Hoffman DS, Nitti VW. PMID: 26902625.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol. 2016 Sep; 196(3):791-800. Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C, 191622-096 Investigators . PMID: 27038769.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    43. Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics. Curr Med Res Opin. 2016; 32(4):621-38. Wagg A, Nitti VW, Kelleher C, Castro-Diaz D, Siddiqui E, Berner T. PMID: 26828974.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    44. Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications. Urology. 2016 05; 91:46-51. Younger A, Rac G, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, Maclachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner E. PMID: 26845051.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    45. Cardiovascular Safety of ß3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome. Eur Urol. 2016 Feb; 69(2):311-23. Rosa GM, Ferrero S, Nitti VW, Wagg A, Saleem T, Chapple CR. PMID: 26422675.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    46. The underactive bladder: a new clinical concept? Eur Urol. 2015 Sep; 68(3):351-3. Chapple CR, Osman NI, Birder L, van Koeveringe GA, Oelke M, Nitti VW, Drake MJ, Yamaguchi O, Abrams P, Smith PP. PMID: 25770481.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    47. Evaluating patients' symptoms of overactive bladder by questionnaire: the role of urgency in urinary frequency. Urology. 2014 Nov; 84(5):1039-43. Mitchell SA, Brucker BM, Kaefer D, Aponte M, Rosenblum N, Kelly C, Hickling D, Nitti VW. PMID: 25443897.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Efficacy of the ß3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials. Eur Urol. 2015 Jan; 67(1):11-14. Chapple C, Khullar V, Nitti VW, Frankel J, Herschorn S, Kaper M, Blauwet MB, Siddiqui E. PMID: 25092537.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    49. Urodynamics. Urol Clin North Am. 2014 Aug; 41(3):xiii. Brucker BM, Nitti VW. PMID: 25063604.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB). Neurourol Urodyn. 2014 Jul; 33 Suppl 3:S26-31. Cruz F, Nitti V. PMID: 25042140.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    51. The virtue sling--a new quadratic sling for postprostatectomy incontinence--results of a multinational clinical trial. Urology. 2014 Aug; 84(2):433-8. Comiter CV, Rhee EY, Tu LM, Herschorn S, Nitti VW. PMID: 24972946.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    52. Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. Int Urogynecol J. 2014 Dec; 25(12):1655-63. Cardozo L, Staskin D, Currie B, Wiklund I, Globe D, Signori M, Dmochowski R, MacDiarmid S, Nitti VW, Noblett K. PMID: 24859795.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    53. Correlation of patient perception of pad use with objective degree of incontinence measured by pad test in men with post-prostatectomy incontinence: the SUFU Pad Test Study. J Urol. 2014 Sep; 192(3):836-42. Nitti VW, Mourtzinos A, Brucker BM, SUFU Pad Test Study Group . PMID: 24650425.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    54. The efficacy and tolerability of the ß3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients. Age Ageing. 2014 Sep; 43(5):666-75. Wagg A, Cardozo L, Nitti VW, Castro-Diaz D, Auerbach S, Blauwet MB, Siddiqui E. PMID: 24610862.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    55. Onset of action of the ß3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. World J Urol. 2014 Dec; 32(6):1565-72. Chapple CR, Nitti VW, Khullar V, Wyndaele JJ, Herschorn S, van Kerrebroeck P, Blauwet MB, Siddiqui E. PMID: 24458878.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    56. Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease. Clinics (Sao Paulo). 2014; 69(12):817-22. Gomes CM, Sammour ZM, Bessa Junior Jd, Barbosa ER, Lopes RI, Sallem FS, Trigo-Rocha FE, Bruschini H, Nitti VW, Srougi M. PMID: 25627993.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    57. Artificial urinary sphincter revision: the role of ultrasound. Urology. 2013 Dec; 82(6):1424-8. Brucker BM, Demirtas A, Fong E, Kelly C, Nitti VW. PMID: 24295256.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Reply: To PMID 24295256. Urology. 2013 Dec; 82(6):1429. Brucker BM, Nitti VW. PMID: 24295258.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014 Feb; 65(2):389-98. Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, Koelbl H, van Kerrebroeck P, Wein AJ. PMID: 24184024.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    60. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn. 2014 Jan; 33(1):17-30. Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC. PMID: 24127366.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimals
    61. Uterine sparing robotic-assisted laparoscopic sacrohysteropexy for pelvic organ prolapse: safety and feasibility. J Endourol. 2013 Sep; 27(9):1131-6. Lee T, Rosenblum N, Nitti V, Brucker BM. PMID: 23713544.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    62. Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool. BMC Neurol. 2013 Jul 09; 13:78. Bates D, Burks J, Globe D, Signori M, Hudgens S, Denys P, Macdiarmid S, Nitti V, Odderson I, Ross AP, Chancellor M. PMID: 23837535.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    63. Urodynamics and safety of the ß3-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction. J Urol. 2013 Oct; 190(4):1320-7. Nitti VW, Rosenberg S, Mitcheson DH, He W, Fakhoury A, Martin NE. PMID: 23727415.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    64. Urodynamics for clinically suspected obstruction after anti-incontinence surgery in women. J Urol. 2013 Aug; 190(2):598-602. Aponte MM, Shah SR, Hickling D, Brucker BM, Rosenblum N, Nitti VW. PMID: 23567748.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    65. Selective ß3-adrenoceptor agonists for the treatment of overactive bladder. J Urol. 2013 Oct; 190(4):1173-80. Andersson KE, Martin N, Nitti V. PMID: 23458471.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    66. Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients. Int J MS Care. 2013; 15(4):182-92. Burks J, Chancellor M, Bates D, Denys P, Macdiarmid S, Nitti V, Globe D, Signori M, Hudgens S, Odderson I, Panicker J, Ross AP. PMID: 24453782.
      View in: PubMed   Mentions:
    67. Management of recurrent urinary tract infections in healthy adult women. Rev Urol. 2013; 15(2):41-8. Hickling DR, Nitti VW. PMID: 24082842.
      View in: PubMed   Mentions:
    68. Comparison of urodynamic findings in women with anatomical versus functional bladder outlet obstruction. Female Pelvic Med Reconstr Surg. 2013 Jan-Feb; 19(1):46-50. Brucker BM, Shah S, Mitchell S, Fong E, Nitti MD, Kelly CE, Rosenblum N, Nitti VW. PMID: 23321659.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    69. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013 Jun; 189(6):2186-93. Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C, EMBARK Study Group . PMID: 23246476.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    70. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012 Dec; 188(6 Suppl):2464-72. Winters JC, Dmochowski RR, Goldman HB, Herndon CD, Kobashi KC, Kraus SR, Lemack GE, Nitti VW, Rovner ES, Wein AJ, American Urological Association , Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction . PMID: 23098783.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    71. Results of a randomized phase III trial of mirabegron in patients with overactive bladder. J Urol. 2013 Apr; 189(4):1388-95. Nitti VW, Auerbach S, Martin N, Calhoun A, Lee M, Herschorn S. PMID: 23079373.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCTClinical Trials
    72. Complications of midurethral slings and their management. Can Urol Assoc J. 2012 Oct; 6(5 Suppl 2):S120-2. Nitti VW. PMID: 23092771.
      View in: PubMed   Mentions:
    73. Appropriate workup for lower urinary tract symptoms in men. Can Urol Assoc J. 2012 Oct; 6(5 Suppl 2):S141-2. Nitti VW. PMID: 23092780.
      View in: PubMed   Mentions:
    74. Evaluation and management of outlet obstruction in women without anatomical abnormalities on physical exam or cystoscopy. Curr Urol Rep. 2012 Oct; 13(5):356-62. Hickling D, Aponte M, Nitti V. PMID: 22872500.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    75. Urodynamic findings in women with insensible incontinence. Int J Urol. 2013 Apr; 20(4):429-33. Brucker BM, Fong E, Kaefer D, Shah S, Rosenblum N, Nitti VW. PMID: 22970923.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    76. Midurethral slings for all stress incontinence: a urology perspective. Urol Clin North Am. 2012 Aug; 39(3):299-310. Lee E, Nitti VW, Brucker BM. PMID: 22877712.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    77. Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women. Urology. 2012 Jul; 80(1):55-60. Brucker BM, Fong E, Shah S, Kelly C, Rosenblum N, Nitti VW. PMID: 22748864.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    78. Long-term continence after surgery--what can we tell patients? J Urol. 2012 Apr; 187(4):1157-8. Nitti VW. PMID: 22335877.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    79. Can noninvasive evaluation of benign prostatic obstruction be optimized? Curr Opin Urol. 2012 Jan; 22(1):1-6. Løvvik A, Yaqub S, Oustad H, Sand TE, Nitti VW. PMID: 22080874.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    80. A new quadratic sling for male stress incontinence: retrograde leak point pressure as a measure of urethral resistance. J Urol. 2012 Feb; 187(2):563-8. Comiter CV, Nitti V, Elliot C, Rhee E. PMID: 22177174.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    81. Clinical testing for overactive bladder. Can Urol Assoc J. 2011 Oct; 5(5 Suppl 2):S137-8. Nitti V. PMID: 21989526.
      View in: PubMed   Mentions:
    82. Treatment of post-prostatectomy incontinence with male slings in patients with impaired detrusor contractility on urodynamics and/or who perform Valsalva voiding. J Urol. 2011 Oct; 186(4):1370-5. Han JS, Brucker BM, Demirtas A, Fong E, Nitti VW. PMID: 21855941.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    83. Surgical management of Skene's gland abscess/infection: a contemporary series. Int Urogynecol J. 2012 Feb; 23(2):159-64. Shah SR, Biggs GY, Rosenblum N, Nitti VW. PMID: 21732101.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    84. Contemporary management of postprostatectomy incontinence. Eur Urol. 2011 Jun; 59(6):985-96. Bauer RM, Gozzi C, Hübner W, Nitti VW, Novara G, Peterson A, Sandhu JS, Stief CG. PMID: 21458914.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    85. Editorial comment. Urology. 2011 Feb; 77(2):325; author reply 325. Nitti VW. PMID: 21295250.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    86. Female urethral reconstruction. Urol Clin North Am. 2011 Feb; 38(1):55-64, vi. Rosenblum N, Nitti VW. PMID: 21353080.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    87. Editorial comment. Urology. 2011 Feb; 77(2):479; author reply 480. Nitti VW. PMID: 21295255.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    88. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol. 2010 Dec; 184(6):2416-22. Dmochowski R, Chapple C, Nitti VW, Chancellor M, Everaert K, Thompson C, Daniell G, Zhou J, Haag-Molkenteller C. PMID: 20952013.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCTClinical Trials
    89. Urinary incontinence. Prim Care. 2010 Sep; 37(3):599-612, ix. Fong E, Nitti VW. PMID: 20705201.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    90. Review article: Mid-urethral synthetic slings for female stress urinary incontinence. BJU Int. 2010 Sep; 106(5):596-608. Fong ED, Nitti VW. PMID: 21050350.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    91. Efficacy of fesoterodine over 24 hours in subjects with overactive bladder. Curr Med Res Opin. 2010 Apr; 26(4):813-8. Staskin D, Michel MC, Nitti V, Morrow JD, Wang J, Guan Z. PMID: 20121659.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    92. Can we predict which patient will fail drug treatment for overactive bladder? A think tank discussion. Neurourol Urodyn. 2010 Apr; 29(4):652-7. Nitti VW, Kopp Z, Lin AT, Moore KH, Oefelein M, Mills IW. PMID: 20432330.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    93. Outcomes of patients lost to followup after mid urethral synthetic slings--successes or failures? J Urol. 2010 Apr; 183(4):1455-8. Ballert KN, Rose AE, Biggs GY, Rosenblum N, Nitti VW. PMID: 20171698.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    94. Association between detrusor overactivity and postoperative outcomes in patients undergoing male bone anchored perineal sling. J Urol. 2010 Feb; 183(2):641-5. Ballert KN, Nitti VW. PMID: 20018325.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int. 2010 May; 105(9):1268-75. Nitti VW, Rovner ES, Bavendam T. PMID: 19889062.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    96. Fistulization between ectopic ureteral stump and uterus following nephroureterectomy: case report. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Dec; 20(12):1505-7. Mufarrij PW, Ballert KN, Nitti VW. PMID: 19444370.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Efficacy and tolerability of fesoterodine in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jul; 20(7):827-35. Sand PK, Morrow JD, Bavendam T, Creanga DL, Nitti VW. PMID: 19495545.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    98. Artificial urinary sphincter versus male sling for post-prostatectomy incontinence--what do patients choose? J Urol. 2009 Mar; 181(3):1231-5. Kumar A, Litt ER, Ballert KN, Nitti VW. PMID: 19152937.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    99. Defining efficacy in the treatment of overactive bladder syndrome. Rev Urol. 2009; 11(4):196-202. Shah S, Nitti VW. PMID: 20111632.
      View in: PubMed   Mentions:
    100. Patient-reported outcomes for tension-free vaginal tape-obturator in women treated with a previous anti-incontinence procedure. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Mar; 20(3):331-5. Biggs GY, Ballert KN, Rosenblum N, Nitti V. PMID: 19107314.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    101. Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach. J Urol. 2009 Feb; 181(2):679-84. Ballert KN, Biggs GY, Isenalumhe A, Rosenblum N, Nitti VW. PMID: 19091337.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    102. Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study. Mayo Clin Proc. 2008 Sep; 83(9):1002-10. MacDiarmid SA, Peters KM, Chen A, Armstrong RB, Orman C, Aquilina JW, Nitti VW. PMID: 18775200.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    103. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology. 2008 Sep; 72(3):488-93. Rovner ES, Rackley R, Nitti VW, Wang JT, Guan Z, 037 Study Group . PMID: 18639327.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    104. Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008 May; 71(5):839-43. Khullar V, Rovner ES, Dmochowski R, Nitti V, Wang J, Guan Z. PMID: 18342923.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    105. Urodynamics, Incontinence, and Neurourology: Highlights from the Society for Urodynamics and Female Urology Annual Winter Meeting, February 28-March 2, 2008, Miami, FL. Rev Urol. 2008; 10(3):229-31. Nitti VW. PMID: 18836560.
      View in: PubMed   Mentions:
    106. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol. 2007 Dec; 178(6):2488-94. Nitti VW, Dmochowski R, Sand PK, Forst HT, Haag-Molkenteller C, Massow U, Wang J, Brodsky M, Bavendam T. PMID: 17937959.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    107. Effect of tension-free vaginal tape and TVT-obturator on lower urinary tract symptoms other than stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Mar; 19(3):335-40. Ballert KN, Kanofsky JA, Nitti VW. PMID: 17874026.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    108. Primary bladder neck obstruction in men, women, and children. Curr Urol Rep. 2007 Sep; 8(5):379-84. Padmanabhan P, Nitti VW. PMID: 17880837.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    109. The male perineal sling: assessment and prediction of outcome. J Urol. 2007 Apr; 177(4):1414-8. Fischer MC, Huckabay C, Nitti VW. PMID: 17382743.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    110. Comparison between reduction in 24-hour pad weight, International Consultation on Incontinence-Short Form (ICIQ-SF) score, International Prostate Symptom Score (IPSS), and Post-Operative Patient Global Impression of Improvement (PGI-I) score in patient evaluation after male perineal sling. Neurourol Urodyn. 2007; 26(1):8-13. Twiss CO, Fischer MC, Nitti VW. PMID: 17016797.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    111. Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol. 2006 Nov; 176(5):2093-7. Akikwala TV, Fleischman N, Nitti VW. PMID: 17070266.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    112. Tolterodine for treatment of overactive bladder. Urol Clin North Am. 2006 Nov; 33(4):447-53, viii. Kanofsky JA, Nitti VW. PMID: 17011380.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    113. Female stress urinary incontinence: how do patient and physician perspectives correlate in assessment of outcomes? Curr Opin Urol. 2006 Jul; 16(4):212-8. Padmanabhan P, Nitti VW. PMID: 16770116.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    114. Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia. BJU Int. 2006 Jun; 97(6):1262-6. Nitti VW, Dmochowski R, Appell RA, Wang JT, Bavendam T, Guan Z, 037 Study Group . PMID: 16686723.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    115. Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies. Curr Med Res Opin. 2006 May; 22(5):851-60. Denys P, Corcos J, Everaert K, Chartier-Kastler E, Fowler C, Kalsi V, Nitti V, Schulte-Baukloh H, Schurch B. PMID: 16709307.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    116. Transdermal delivery of drugs for urologic applications: basic principles and applications. Urology. 2006 Apr; 67(4):657-64. Nitti VW, Sanders S, Staskin DR, Dmochowski RR, Sand PK, MacDiarmid S, Maibach HI. PMID: 16618554.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    117. Improving the global management of the neurogenic bladder patient: part I. The complexity of patients. Curr Med Res Opin. 2006 Feb; 22(2):359-65. Denys P, Corcos J, Everaert K, Chartier-Kastler E, Fowler C, Kalsi V, Nitti V, Schulte-Baukloh H, Schurch B. PMID: 16466608.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    118. Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art. Rev Urol. 2006; 8(4):198-208. Nitti VW. PMID: 17192799.
      View in: PubMed   Mentions:
    119. Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials. World J Urol. 2005 Sep; 23(4):263-70. Dmochowski RR, Nitti V, Staskin D, Luber K, Appell R, Davila GW. PMID: 16151816.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    120. Bladder-health diaries: an assessment of 3-day vs 7-day entries. BJU Int. 2005 Nov; 96(7):1049-54. Dmochowski RR, Sanders SW, Appell RA, Nitti VW, Davila GW. PMID: 16225527.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    121. Surgical treatment of stress urinary incontinence in women: is "clinical effectiveness" a valid concept? Curr Urol Rep. 2005 Sep; 6(5):319-21. Nitti VW. PMID: 16120230.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    122. Diagnosis and treatment of primary bladder neck obstruction in men. Curr Urol Rep. 2005 Jul; 6(4):271-5. Huckabay C, Nitti VW. PMID: 15978226.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    123. Patient perception of videourodynamic testing: a questionnaire based study. J Urol. 2005 Feb; 173(2):555-9. Scarpero HM, Padmanabhan P, Xue X, Nitti VW. PMID: 15643252.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    124. A urodynamics protocol to optimally assess men with post-prostatectomy incontinence. Neurourol Urodyn. 2005; 24(7):622-6. Huckabay C, Twiss C, Berger A, Nitti VW. PMID: 16208638.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    125. Is There a Role for alpha-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia? Rev Urol. 2005; 7 Suppl 4:S49-55. Nitti VW. PMID: 16986055.
      View in: PubMed   Mentions:
    126. Correlation of abdominal leak point pressure with objective incontinence severity in men with post-radical prostatectomy stress incontinence. Neurourol Urodyn. 2005; 24(3):207-10. Twiss C, Fleischmann N, Nitti VW. PMID: 15791628.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    127. Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol. 2005; 7 Suppl 6:S14-21. Nitti VW. PMID: 16986024.
      View in: PubMed   Mentions:
    128. Primary bladder neck obstruction in men and women. Rev Urol. 2005; 7 Suppl 8:S12-7. Nitti VW. PMID: 16985885.
      View in: PubMed   Mentions:
    129. Pelvic floor reconstruction: state-of-the-art and beyond. Urol Clin North Am. 2004 Nov; 31(4):757-67. Fleischmann NB, Nitti VW. PMID: 15474603.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    130. Voiding dysfunction in young, nulliparous women: symptoms and urodynamic findings. Int Urogynecol J Pelvic Floor Dysfunct. 2004 Nov-Dec; 15(6):373-7; discussion 377. Rosenblum N, Scarpero HM, Nitti VW. PMID: 15278258.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    131. Degree of bother caused by nocturia in women. Neurourol Urodyn. 2004; 23(2):130-3. Fiske J, Scarpero HM, Xue X, Nitti VW. PMID: 14983424.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    132. Duloxetine: a new pharmacologic therapy for stress urinary incontinence. Rev Urol. 2004; 6 Suppl 3:S48-55. Nitti VW. PMID: 16985864.
      View in: PubMed   Mentions:
    133. An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol. 2003 Oct; 170(4 Pt 1):1237-41. Xiao CG, Du MX, Dai C, Li B, Nitti VW, de Groat WC. PMID: 14501733.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    134. Management of obstructive voiding dysfunction after incontinence surgery: lessons learned. Urology. 2003 Sep; 62(3):391-9. Gomelsky A, Nitti VW, Dmochowski RR. PMID: 12946730.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    135. Endoscopic evacuation of Durasphere. Urology. 2003 Jul; 62(1):135-7. Hartanto VH, Lightner DJ, Nitti VW. PMID: 12837442.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    136. Recent advances in management of female lower urinary tract trauma. Curr Opin Urol. 2003 Jul; 13(4):279-84. Hartanto VH, Nitti VW. PMID: 12811291.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    137. Vaginal granulation tissue secondary to bone anchors: experience in two patients. J Urol. 2003 Jun; 169(6):2300-1. Stember DS, Scarpero HM, Nitti VW. PMID: 12771779.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    138. American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. Urology. 2003 Jun; 61(6):1118-22. Scarpero HM, Fiske J, Xue X, Nitti VW. PMID: 12809877.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansPHPublic Health
    139. Repeat urethrolysis after failed urethrolysis for iatrogenic obstruction. J Urol. 2003 Mar; 169(3):1013-6. Scarpero HM, Dmochowski RR, Nitti VW. PMID: 12576834.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    140. Transdermal therapy for overactive bladder: present and future. Rev Urol. 2003; 5 Suppl 8:S31-6. Nitti VW. PMID: 16985988.
      View in: PubMed   Mentions:
    141. Management of urinary retention and obstruction following surgery for stress urinary incontinence. Curr Urol Rep. 2002 Oct; 3(5):354-9. Scarpero HM, Nitti VW. PMID: 12354342.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    142. Lower urinary tract symptoms in young men: videourodynamic findings and correlation with noninvasive measures. J Urol. 2002 Jul; 168(1):135-8. Nitti VW, Lefkowitz G, Ficazzola M, Dixon CM. PMID: 12050507.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    143. Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms. Urology. 2002 Jun; 59(6):856-60. Barnes NM, Dmochowski RR, Park R, Nitti VW. PMID: 12031368.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    144. Early results of pubovaginal sling lysis by midline sling incision. Urology. 2002 Jan; 59(1):47-51; discussion 51-2. Nitti VW, Carlson KV, Blaivas JG, Dmochowski RR. PMID: 11796279.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    145. Clinical impact of overactive bladder. Rev Urol. 2002; 4 Suppl 4:S2-6. Nitti VW. PMID: 16986018.
      View in: PubMed   Mentions:
    Victor's Networks
    Concepts (289)
    Derived automatically from this person's publications.
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _